U.S., Dec. 18 -- ClinicalTrials.gov registry received information related to the study (NCT07288190) titled 'Phase 2b, Open Label, Multisite, Randomized Crossover Study of DPP Versus 2PR' on Feb. 18.
Brief Summary: To evaluate adherence to a single dual-prevention pill (DPP) compared with a two-pill regimen (2PR) for pre-exposure prophylaxis (PrEP) and pregnancy prevention in women without HIV.
Study Start Date: March 15, 2026
Study Type: INTERVENTIONAL
Condition:
Pregnancy
HIV Infections
Intervention:
DRUG: DPP
Daily, single, co-formulated, FTC/TDF + combined ethinyl estradiol/levonorgestrel oral contraceptive pill
DRUG: 2PR
Daily, two-pill regimen of oral FTC/TDF and ethinyl estradiol/levonorgestrel oral contraceptive pill
DRUG...